]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both agematched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template-at the single-subject and group level-independently for subjects with
F]-FDG PET scans can be analyzed using voxel-based statistical methods such as Statistical Parametric Mapping (SPM) that provide statistical maps of brain abnormalities in single patients. In order to perform SPM, a "spatial normalization" of an individual's PET scan is required to match a reference PET template. The PET template currently used for SPM normalization is based on [ ]-FDG PET aging and dementia-specific template for spatial normalization, based on images derived from both agematched controls and patients. We hypothesized that this template would increase spatial normalization accuracy and thereby preserve crucial information for research and diagnostic purposes. We investigated the statistical sensitivity and registration accuracy of normalization procedures based on the standard and new template-at the single-subject and group level-independently for subjects with 
Introduction
]-FDG PET) maps the distribution of glucose metabolism, which is driven mainly at the synaptic level (Magistretti 2000) . Pathologic phenomena leading to neuritic dysfunction affect synaptic glucose consumption, before causing cell death and detectable atrophy. As such, [ 18 F]-FDG PET is a proxy for reduced glucose utilization by viable but potentially vulnerable neurones. [ 18 F]-FDG PET is thus a validated diagnostic tool, enabling the evaluation of brain function and dysfunction through regional changes in cerebral glucose metabolism (Sestini et al. 2010; Herholz et al. 2002; Anchisi et al. 2005; Salmon et al. 2009 ).
Twenty years of [
18 F]-FDG PET imaging research have provided consistent patterns of hypometabolism/functional derangement, characterizing the different types of neurodegenerative diseases and significantly supporting clinical diagnosis (Teune et al. 2010; Teipel et al. 2013; Perani 2008) . PET neuroimaging is gaining increasing importance in supporting differential diagnosis and it is now considered an essential part of the diagnostic protocol, helping to recognize typical patterns of dementia (McKeith et al. 2005; Dubois et al. 2010; McKhann et al. 2011; Sperling et al. 2011; Albert et al. 2011; Rascovsky et al. 2011) . In Alzheimer's disease (AD), such a marker of functional neurodegeneration is considered to be more sensitive and to allow earlier diagnosis than conventional MRI .
At present, the clinical use of [
F]-FDG PET imaging is mostly limited to the visual inspection of [
18 F]-FDG uptake. This characterization is not optimal for a reliable diagnosis, especially for the earliest disease stages, when only subtle metabolic abnormalities may be present. It is also not ideal for localizing the topographical patterns that characterize different dementia conditions.
Approaches that overcome the subjective aspect of visual inspection include voxel-based analysis techniques, such as Statistical Parametrical Mapping (SPM) (Signorini et al. 1999 ), Neurostat (Minoshima et al. 1995) and t-sum (Herholz et al. 2002) . These statistical parametric mapping procedures provide statistical maps of brain abnormality in single individuals, and are more accurate in detecting early changes and predicting subsequent conversion (Patterson et al. 2011; Berti et al. 2010; Chételat et al. 2003; Mosconi et al. 2008; Caroli et al. 2012) .
The SPM package (SPM; Wellcome Trust Centre for Neuroimaging, London, U.K.), has been widely applied in [ 18 F]-FDG PET analysis for neurology research (Perani 2008) . At the single-subject level, SPM provides the means for generating objective statistical maps, resulting from the comparison of one patient's scan to a group of control scans at the voxel level. To perform SPM, a "spatial normalization" of individual images is a mandatory prerequisite for statistical analysis. Spatial normalization is usually accomplished by spatially warping individual images to a template space, using an image registration algorithm. Spatial normalization requires a nonlinear registration of PET images with a reference PET template, which is usually the standard [ 15 O]-H 2 O template provided with the SPM software. After a geometric transformation, individual PET scans are transformed to a common neuroanatomical space, allowing voxelwise statistical analysis. When comparing a single [ F]-FDG PET scan against a group of normal scans, it is important to minimize morphological differences between the patient and the normal scans, which could affect the metabolic comparisons producing statistical maps. Normalization indeed reduces morphological differences and anatomical variance in controls.
Depending on the PET radioligand, regional tracer uptake (i.e. the pattern of signal intensities in the [ ]-H 2 O PET template normalization is that specific morphological features of an individual FDG brain cannot be matched to the template. This process introduces a potential loss of spatial normalisation accuracy-and in consequence, statistical efficiency-when comparing pathological scans against normal scans. This is especially so when studying neurodegenerative diseases, where morphological heterogeneity can be greatly increased by the underlying pathological process (Ishii et al. 2001) .
Spatial normalization in SPM is based on minimizing the difference between an image and some template(s), subject to constraints on the plausibility of different deformations (Ashburner and Friston 1999) . To find the optimal transformation, the image being normalized and the template(s) must have high mutual information that rests on the same spatial deployment of features (Ishii et al. 2001; Gispert et al. 2003) . The choice of PET template image used for spatial normalization has been shown to influence statistical outcome (Gispert et al. 2003 (Ishii et al. 2001; Gispert et al. 2003) .
The normalization bias-in the comparison between patients and controls-using voxelwise methods will tend to occur in atrophied brain regions. This normalization effect on statistical comparisons of metabolism, derived using the same spatial normalization for anatomically normal and atrophied brains, was investigated by Ishii et al. (2001) , confirming that atrophied brains show artifacts introduced by the spatial normalization process. Crivello et al. (2002) also emphasized that spatial normalization can potentially confound quantification of inter-subject metabolic differences. Spatial normalization of pathological scans by matching them to a template derived only from a healthy control population will necessarily try to make pathological brains look normal. The spatial transformations will attempt to reduce any mismatch between image and template-and potentially confound anatomical and metabolic differences. A strategy to overcome this confound would be to use the scans of patients to compute a pathology-specific template that is representative of the population under investigation. This procedure should minimize conflation of anatomical and metabolic differences in the way that has been established in structural MRI procedures such as Voxel Based Morphometry (VBM) (Good et al. 2001) or through registration schemes that create population-specific templates, such as DARTEL (Ashburner 2007 (Ishii et al. 2001; Gispert et al. 2003) , and-so far-has been ignored in the context of the analysis of single patients with suspected dementia. SPM is not intended for the detection of metabolic dysfunction with a particular tracer, in a particular neurological condition (i.e., dementia) at the single-subject level and does not come prepackaged with an [ ]-FDG PET population-specific template for spatial normalization, based on images derived from both patients (sample of scans representative of the various forms of dementia in the population) and age-matched controls. Our strategy for constructing a reference template for this particular application eschews any assumptions about the mapping between structural and metabolic anatomy that underlies the use of MRI-based registration. In other words, the functional anatomy defined operationally by regional glucose metabolism is used directly to provide an average template. This ensures that the spatial scale of metabolic anatomy that is conserved over subjects is retained in the template-and is not confounded by matching the detailed anatomy in high resolution structural images. Our hypothesis was that spatial normalization with these templates would provide a higher degree of registration accuracy and minimize the conflation of anatomical and metabolic differences between patients and control subjects. To this end, we report a study that comprised the following steps:
1) Creation of an [
18 F]-FDG PET dementia-specific template (Gispert et al. 2003; Wenzel et al. 2010 Table 1 ).
The 60 patients were sampled according to the incidence of degenerative cognitive decline in western countries (e.g. Prince et al. 2011; Bornebroek and Bretelera 2004) , we selected 36 patients who fulfilled clinical consensus criteria for probable AD (Dubois et al. 2010; McKhann et al. 2011 ) (60 % of the overall sample), 12 patients affected by Mild Cognitive Impairment (MCI) (Winblad et al. 2004) , including those fulfilling criteria for prodromal AD Albert et al. 2011) , 6 behavioral variant of Frontotemporal Dementia (bvFTD) (Rascovsky et al. 2011; Neary et al. 1998; McKhann et al. 2001) , and 6 patients affected by Dementia with Lewy bodies (DLB) (McKeith et al. 2005 ).
All healthy subjects and patients provided written consent prior to their inclusion in the study, which was carried out in accordance with the Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.
An [
18 F]-FDG PET brain study was performed in all subjects (healthy controls and patients) according to conventional neurological acquisition protocols and to the European Association of Nuclear Medicine (EANM) guidelines (Bartenstein et al. 2002; Morbelli et al. 2012) .
Before radiopharmaceutical injection, subjects were fasted for at least six hours to ensure measured blood glucose level was <120 mg/dL. Subjects underwent a 3D PET scan (time interval between injection and scan start ranged from 30 to 45 min; scan duration ranged from 10 to 15 min depending on the PET scanner characteristics) after the injection of [
18 F]-FDG (185-250 Mbq: usually, 5-8 mCi via a venous cannula). Images were reconstructed using an ordered subset expectation maximization algorithm in all centers but Amsterdam (which used filtered back projection). Attenuation correction was based on CT scans in Milan, Brescia, Genoa, and Marseille, and on transmission scans in Munich and Amsterdam. Specific software integrated in each scanner was used for scatter correction. The scanner technical details and image acquisition characteristics for scanner type and subject group are reported in Table 1 . Signorini et al. (1999) and according to the procedure for functional normalization described in Gispert et al. (2003) . In particular, to spatially normalize [ 18 F]-FDG PET images with this template, we used the normalization algorithm provided by SPM5, that employs a 12-parameter affine transformation followed by nonlinear deformations. Basis functions for the nonlinear warping were 7×8×7 in x-, y-, and z-dimensions, respectively, with 16 iterations. The following SPM5 default parameter settings were used for estimating the spatial transformations: no template and source weighting; 25 mm cutoff; medium regularization; 16 nonlinear iterations. The "Preserve Concentration" setting, along with trilinear interpolation, was used to create the normalized images. The field of view (FOV) used for the spatially normalized images was set to that of the other templates released with SPM5, with an isotropic voxel size of 2 mm. 
Intensity Normalization of [ 18 F]-FDG PET Images
The final set of normalized images were first "count normalized" (Yakushev et al. 2009 ) in order to standardize the magnitude of all voxel values in every image using the count scaling algorithm implemented as default by SPM (Friston et al. 1994; Buchert et al. 2005) and then rescaled to have the same mean intensities prior to averaging, so that all images would contribute equally to the template: this accounts for center-specific image scaling as well as for variability in the amount of injected radioactivity. Furthermore, it ensures that the intensity of each image (normal or pathological) contributes in a balanced way to the average image (template). Distance analysis (Kherif et al. 2003 ) was used to perform outlier diagnosis, with respect to inter-subject variation and noise from outside the brain. First, the SPM masking toolbox (Ridgway et al. 2009 ) was used 1) to compute a mean image from the spatially and intensity normalized [ 18 F]-FDG PET images and 2) to create a template-specific explicit optimal threshold within-brain mask. The within-brain mask was used to eliminate variance due to inter-subject variation and noise from outside the brain. We first inspected a matrix of distances between all pairs of images, which indicated how far any given scan was from each another, thus revealing outlier scans.
We then tested for the influence of a particular scan on the average (Cook test). This averaging procedure can be regarded as a form of robust averaging that suppresses outliers.
"Soft Mean" and Smoothing of [ 18 F]-FDG PET Images
The final spatially and intensity normalized [ 18 F]-FDG PET images were averaged using a "soft mean", to obtain a mean [ 18 F]-FDG PET image that conforms to the standard stereotaxic space defined by the MNI/International Consortium for Brain Mapping (ICBM) 152 MNI templates, as supplied with SPM. Depending on the field of view, this soft-mean results in a slightly different variance at voxels where different numbers of images have contributed, meaning that-at each voxelthe mean was computed via a floating-point relative accuracy function over only those images that have a value in that location.
The resulting "[ (Signorini et al. 1999) .
Our validation was focused on the effect of using the [ (Bartenstein et al. 2002; Morbelli et al. 2012 ) under the same conditions and using the same scanning protocol used for normal and patient scans selected for the creation of the [ 18 F]-FDG PET template. Controls had a negative history for neuropsychiatric and neurological disorders or chronic illness. Balancing for the impact of different scanner among centers, with the only criteria to cover the age range of the demented population, a total of 132 scans of HC (62 men and 70 women; mean age= 65.19 years; SD=9.21 years; age range=40-83 years) was used: uHSR database (19 subjects), EADC database: Brescia (27 subjects), Genoa (36 subjects), Munich (19 subjects), Amsterdam (21 subjects), Marseille (10 subjects) (see Table 1 for details).
We selected a large sample of [ 18 F]-FDG PET scans (n= 67) pooled from the dementia population acquired at the uHSR center in Milan, in order to compare single-subjectversus healthy control group statistical effects in specific brain regions. Namely, we selected 23 cases diagnosed with AD (Dubois et al. 2010; McKhann et al. 2011) or prodromal AD (i.e., MCI patients with positive biomarkers of AD) (Sperling et al. 2010; Albert et al. 2011) ; 24 cases fulfilling current clinical criteria for bvFTD (Rascovsky et al. 2011; Neary et al. 1998; McKhann et al. 2001 ) and 20 DLB patients (McKeith et al. 2005) . (Evans et al. 1993) , regardless of the tracer employed.
To spatially normalize the [ 18 F]-FDG PET images to this template, we used the normalization algorithm provided by SPM5 with the following parameter settings including 12-parameters' affine transformation, 7×8×7 discrete cosine transform basis functions, no template and source weighting; discrete cosine transform cutoff: 25 mm; 16 nonlinear iterations and the nonlinear regularization term set to 1. No modulation ("preserve concentrations") and trilinear interpolation was used during final re-slicing. The dimensions of normalized images were x=−78:78; y=−112:76; z=−50:85 mm from the anterior commissure with 2×2×2 mm 3 isotropic voxels. A visual inspection of all normalized images was performed with the exclusion of images with partial FOVs or where the normalization procedure failed, with the purpose to confirm spatial normalization convergence.
The "[
15 O]-H 2 O" normalized scans underwent further processing steps in order to minimize possible differences induced by the specific imaging characteristics and scanning protocols of each PET center. A two-pass maskednormalization was applied with the purpose of include in the statistical analysis only those signal voxels included in the mask. In the first pass a scanner-specific mask was applied in order to exclude voxels not included in all the images from the same scanner. In the second pass a conjoint mask was created as a binary image including only voxels covered by each image from each considered scanner.
Furthermore, the "[ 15 O]-H 2 O" normalized scans from healthy control database underwent an intensity rescaling and a global count intensity normalization to have the same mean intensities (Friston et al. 1994; Buchert et al. 2005 ) and a subsequent distance analysis to exclude outliers.
The PET images for both normal subjects and patients were spatially normalized to the [ . A statistical map, or SPM-t, was obtained for each of the two functional normalization procedure, estimating potential hypometabolic areas for each healthy subject, as compared to the remaining controls. Misclassified individuals were considered when cluster of voxels were present in the SPM-t with a minimum extent of 10 voxels and surviving at p<0.05 FWE-corrected threshold at a voxel level.
Single-Patient SPM Analysis
A single patient vs. healthy control group SPM analysis was performed for all considered [ Each single-patient [
18 F]-FDG PET image was tested for relative 'hypometabolism' by comparison with normal controls on a voxel-by-voxel basis-using the two sample t-test design of SPM5. Age was included as a covariate. Due to the lack of any significant difference in metabolic activity of male and female demented patients (Minoshima et al. 1997 ), gender was not controlled in the analysis.
Global normalization of voxel values used proportional scaling to a mean voxel value of 6.5 mg/100 mL/min. This value was derived from a previous study where it was successfully applied in SPM analysis for single subjects (see Signorini et al. (1999) for details). The grey matter threshold was left at the default 0.8 value (i.e., the mean brain intensity was computed from only those voxels with intensity above 0.8 of the mean over the entire scan). Additionally, voxel-wise comparisons were made using a within-brain comparisonspecific explicit optimal threshold [ 18 F]-FDG mask created using the SPM masking toolbox (Ridgway et al. 2009 Subsequently, the analyses generated a t statistic for each voxel as specified by the linear contrast.
a. Hypometabolism: SPM-t approach SPM-t maps were generated to identify areas of significant hypometabolism (significant SPM-t). We investigated hypometabolic brain areas at a significance level of p= 0.05, corrected for multiple comparisons with the familywise error (FWE) option at the voxel level. Only clusters containing more than 100 voxels were considered to be significant (see Table 2 ). b. Hypometabolism: ROI approach
We used a region of interest (ROI) approach-by comparing statistical t-values extracted from SPM-t of hypometabolism in typical hypometabolic regions for each specific dementia condition. To obtain an unbiased estimate of hypometabolism from a priori ROIs associated with each of the three pathologies (i.e., AD or early AD, bvFTD and DLB), we created a 16 mm radius spherical ROI centered on the median reference x, y and z coordinates reported in previous investigations: the posterior cingulate cortex (PCC) for AD or prodromal AD (Anchisi et al. 2005; Teune et al. 2010; Chételat et al. 2003) , the mid-ventral portion of the orbito-frontal gyrus (vmPFC) for bvFTD (Teune et al. 2010; Salmon et al. 2003) , and the right middle occipital cortex (RmOC) for DLB (Teune et al. 2010; Mori et al. 2006) .
The closest local maxima to the reference x, y and z coordinates in the a priori pathology-specific brain region was selected with the Anatomy Toolbox (Eickhoff et al. 2005) Single-patient hypometabolism contrast maps resulting from single-patient SPM analysis for each of the two functional normalization procedures, were statistically tested at group-level for disease-specific groups (only AD/prodromal AD, only bvFTD, and only DLB). Two separate one sample t-test designs in SPM5 were performed for each functional normalization procedures, applying a normalization-specific within-brain explicit mask (as previously described) with the purpose of identifying areas of hypometabolism common to all patients.
For each of the two functional normalization procedures, group SPM-t maps were obtained representing disease-specific patterns of hypometabolism for AD/ prodromal AD, for bvFTD and for DLB (Anchisi et al. 2005; Teune et al. 2010; Chételat et al. 2003; Salmon et al. 2003; Mori et al. 2006 ). These SPM-t maps were assessed at a threshold of p<0.05, FWE corrected for multiple comparisons at a voxel-level and a threshold for minimum spatial extent of ten contiguous voxels. The Anatomic Automatic Labeling software (AAL) was used for anatomical localization of statistically significant clusters.
For visualization purposes only, we computed smoothed histograms (i.e., density plots) to quantify the degree of overlap/separation between the distribution of the voxel values over the whole-brain (see Fig. 5 To assess the diagnostic performance of the use of the [ 18 F]-FDG PET template in detecting both diseasespecific PET patterns and normality, we calculated sensitivity, specificity, area under the ROC curve (AUC) values and a global measure of diagnostic accuracy (i.e., effectiveness). This kind of analysis was applied to the entire cohort of patients and controls considered in the present context. Gold standard for True Positives and True Negatives was the confirmed diagnosis of neurologists at clinical follow-up (18 months after the first evaluation and 15 months after the PET studies). A matrix of distances between all pairs of images revealed the presence of outlier scans (see red values in the right panel of Fig. 1 ). In particular, the Cook test (testing for the influence of a particular scan on the average) showed that five scans deviated further than the critical D value (D=0.036) (see Fig. 1 ), leading to the exclusion of five matched pairs of control-patient images (ten scans).\ Figure 2 shows the difference in intensity within transaxial sections of the resulting [ Fig. 3 .
In all four dementia cases (AD, amnesic MCI, bvFTD and DLB patient), the single-patient analysis, based on the comparison of SPM-t maps from the two normalization procedures, revealed: a) higher local maxima peak values (t-statistic) and b) larger Cluster Extent (K E , number of voxels) when image normalization to the [ 18 F]-FDG PET template was used, highlighting a more extensive hypometabolic pattern (see Fig. 3 and Table 2 for details). In particular:
SPM-t maps of the AD patient showed a bilateral temporo-parietal hypometabolism, particularly involving the precuneus, inferior and superior parietal cortex. Hypometabolic regions were more extended when the subject was normalized to the [ Table 2 panel A).
SPM-t maps of the amnesic MCI patient, after the [ 18 F]-FDG PET normalization procedure, showed a hypometabolic pattern typical of AD pathology, involving temporo-parietal cortex bilaterally, and in addition, the left Fig. 1 On the left panel, the matrix of distances between all scans (55 controls and 55 patients). On the right panel, the Cooks distance revealing the outlier images (red values) with larger values than the critical D value, which were excluded from the final set of images hippocampus, posterior cingulate cortex (PCC) and precuneus (see Table 2B and Fig. 3 panel B) . The same patient, following the [ Figure 4b (middle panel), shows the difference plot (Bland-Altman plot) between the SPM-t values, obtained following the two normalization procedures for each patient of the different dementia subgroup. The difference values are averaged over voxels within the pathologyspecific ROI. The plot establishes that the mean difference between t-values from the two normalization procedures is substantially shifted away from 0 when plotted against the average t-values from the two procedures. Figure 4c (right panel), shows the distribution of the SPM-t values, averaged over the group population and over the pathological-specific ROI voxels. As one can observe, they are more statistically significant when using the [ Table 2 Table 3 and Fig. 5 ).
In the AD/prodromal AD group, a more widespread pattern was detected following the [
18 F]-FDG normalization involving, bilaterally, the precuneus, the mid-posterior cingulate cortex and extensively the parietal lobes (see Table 3 for exact coordinate peaks and localization).
In normalized hypometabolism was limited to two small clusters at parietal sites (see Table 3 for exact coordinate peaks and localization).
Inspection of the density plots (see Fig. 5 
Discussion
We constructed an [ 18 F]-FDG PET dementia-specific template from images obtained from multiple centers. We then validated the use of this new template in spatial normalization-as a prerequisite for statistical comparison of normal and dementia subjects-while controlling for differences due to different scanner characteristics or data-acquisition protocols.
The ; 2) Local maxima for each brain area (in a range of 10mms on x, y or z) were identified at the specific peak coordinates for each normalization procedure; t-statistic values and cluster extents are reported for each local maxima a The AAL (Automated Anatomical Labeling) digital atlas of the human brain was used for localizing and labeling clusters of significant hypometabolism in the different major brain subdivisions b The asterisks indicate local maxima included in the same cluster. (k E ) (cluster extent) indicates the number of voxels included in the cluster We propose that this new template could be useful for both research and clinical purposes, allowing the detection of subtle metabolic abnormalities associated with specific cognitive impairment and the recognition of different patterns of neurodegeneration-particularly at the single-subject level and in early disease stages (see Fig. 3 ). The validity of single-subject analyses was assessed through their consistency with the established relationship between dementia subtypes and hypometabolic patterns (see Fig. 3 and Table 2 ). Improved statistical power using the new [ 18 F]-FDG PET template was confirmed by distributional differences in the final t-statistics testing for single subject effects in a priori pathology-specific ROIs, over a cohort of patients (n>20) for each dementia subtype (Fig. 4) .
Our findings in the amnesic MCI subject (see Table 2 and Fig. 3, Table 2 and Fig. 3,  panel B ). These differences were not evident in the SPM with the [ 15 O]-H 2 O normalization procedure. Thus, the sensitivity to differences in specific brain regions involved in neurodegenerative processes (i.e., hippocampus, inferior temporal and occipital regions) seems to be affected by the quality of spatial normalization (Krishnan et al. 2006; Rorden et al. 2012) .
Our results suggest that the [ 18 F]-FDG PET template provides a higher degree of accuracy, for spatial normalization of [ 18 F]-FDG PET scans. Precise anatomical registration of regional metabolic changes enables voxel by voxel analyses, which has fundamental advantages over visual assessment. To increase diagnostic reliability in early phases of the disease process and make statistically informed decisions about metabolic abnormalities associated with dementia, it is important to increase normalization accuracy in order to reduce random effects due to noise present in individual images, which is especially prevalent in PET (Markiewicz et al. 2009 Fig. 5 ) in areas with typically decreased glucose metabolism in AD (Herholz et al. 2002; Teune et al. 2010; Chételat et al. 2003) , bvFTD (Teune et al. 2010; Salmon et al. 2003) and DLB (Teune et al. 2010; Minoshima et al. 2001) . With respect to the DLB group, occipital hypometabolism has been shown to be a specific topographical marker of this dementia subtype ; associated with DLB-specific clinical symptoms, such as visual hallucinations (Mori et al. 2006 ) that play a key role in the differential diagnosis with respect to AD (McKeith et al. 2005) .
The new [
18 F]-FDG PET template may be useful for clinical research by providing more effective discrimination Fig. 6 a Plot of the cross-classification of binary SPM evaluation outcomes (1=positive, 0=negative for DLB-as evaluated by a neurologist according to the presence/absence of a typical disease-specific FDG-PET pattern of hypometabolism in a voxel-based SPM study, p<0.05, FWE corrected for multiple comparisons generated following normalization with the FDG-template) with the true category to which the subject belongs to, according to disease state (1=True Positive: presence of a true disease state; 0=True Negative: absence of a true disease state). The predicted classification probabilities (Sensitivity and 1-Specificity) are obtained from logistic regression of single-case binary response outcomes on category membership for true PRES-ENCE or ABSENCE of the disease. b Area under the ROC curve (AUC) as a result of plotting Sensitivity (one Highest True Positive probability value: p=0.91) against 1-Specificity (one Lowest False Positive probability value: p=0.045), resulting from the logistic regression of binary SPM evaluation outcomes on true PRESENCE or ABSENCE of disease state between patient groups, particularly at early disease stages (see Fig. 5 ), allowing one to establish more clear-cut anatomo-clinical correlations (Teune et al. 2010 ). The [ 18 F]-FDG PET template may further help in research studies of atypical dementia or in subjects at risk for dementia with the intent to relate specific or subtle hypometabolic patterns, as revealed by SPM, to diverse neuropsychological pictures characterized by precise clinical symptoms.
We evaluated the ability of the new template to help differentiate between various disease conditions and the normal population. We thus determined its diagnostic accuracy using longitudinal clinical assessment of at least 18 months for patients as a gold standard, and a large sample of healthy subjects (n=112). Classification of patients and healthy controls, through SPM-t of hypometabolism, revealed an overall diagnostic accuracy of 94 %. This is in line with accuracies reported for other semi-quantitative measures (see for example Foster et al. (2007) reporting a diagnostic accuracy of 93 %).
Finally, some limits of spatial normalization have to be considered. In cases of severe atrophy, even when the PET image is matched to a bespoke reference template, particular attention is required in the interpretation of statistically significant areas of hypometabolism-specifically in relation to structural information. MRI-aided spatial normalization can be more accurate than normalization based only on functional images (Ashburner and Friston 1999; Martino et al. 2013) , given the better anatomical information and higher spatial resolution. However, many clinical and research protocols for evaluation of dementia include PET imaging but do not necessarily involve MRI, which is necessary for MRI-based spatial normalization in single individuals. In these conditions, an accurate spatial normalization can be achieved by using the dementia-specific FDG-PET template presented here.
Furthermore, when studying neurodegenerative diseases where structural variability is profoundly increased by the underlying neurodegenerative processes, the use of the dementia-specific FDG-PET template for spatial normalization can provide two main benefits: 1) the spatial scale of metabolic anatomy is retained in the template, 2) normal and pathological functional anatomy are both defined operationally by regional glucose metabolism in this template.
In conclusion, we have contributed to optimize the application of SPM to analyze [ 
Information Sharing Statement
The [
18 F]-FDG-PET template presented here will be made available to download in the "Templates" section (http://www.fil.ion.ucl.ac.uk/spm/ext/#tpl) on the SPM (RRID :nif-0000-00343) official website (http://www.fil. ion.ucl.ac.uk/spm/) through the following URL: http:// inlab.ibfm.cnr.it/PET_template.php
